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Specific Filaggrin Mutations Cause Ichthyosis
Vulgaris and Are Significantly Associated with Atopic
Dermatitis in Japan
Toshifumi Nomura1, Masashi Akiyama1, Aileen Sandilands2, Ikue Nemoto-Hasebe1, Kaori Sakai1,
Akari Nagasaki1, Mitsuhito Ota3, Hiroo Hata1, Alan T Evans4, Colin NA Palmer5, Hiroshi Shimizu1
and WH Irwin McLean2
Mutations in the gene encoding filaggrin (FLG) have been identified as the cause of ichthyosis vulgaris (IV) and
shown to be major predisposing factors for atopic dermatitis (AD). However, these studies have been mainly
carried out in European populations. In early 2007, we identified two Oriental-specific FLG mutations in four
Japanese families with IV and reported that filaggrin mutations were also significant predisposing factors for AD
in Japan. However, the frequency of FLG mutations observed in our Japanese AD cohort (5.6%), was much lower
than that seen in Europeans (up to 48%). Here, we studied a further seven Japanese families with IV and
identified two additional nonsense mutations in FLG, S2889X, and S3296X. We found that more than 20% of
patients in our Japanese AD case series carry FLG mutations, and there is significant statistical association
between the four mutations and AD (w2 P¼ 8.4 106; heterozygote odds ratio 7.57, 95% CI 2.84–23.03). These
data emphasize that skin-barrier impairment due to reduced filaggrin expression plays an important role in the
pathogenesis of AD and sheds further light on the genetic architecture of atopy in Japan.
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INTRODUCTION
Ichthyosis vulgaris (IV; OMIM no. 146700) is a very common
genetic disorder of keratinization clinically characterized by
scaling, especially on the extensor limbs, dry skin, and
palmoplantar hyperlinearity (Sybert et al., 1985; Smith et al.,
2006). IV symptoms are most pronounced in winter or in
cold, dry climates. Keratosis pilaris is also a feature and,
importantly, atopic dermatitis (AD) is commonly seen in IV
(Mevorah et al., 1985). Histologically, a decrease in the size
and number or a complete absence of keratohyalin granules
in the epidermis is typically characteristic of IV (Sybert et al.,
1985). Keratohyalin granules are mainly composed of a
4400-kDa polyprotein, profilaggrin. During terminal differ-
entiation of keratinocytes, profilaggrin is processed into
filaggrin, which plays an essential role for epidermal barrier
formation and hydration (Irvine and McLean, 2006).
Recently, loss-of-function mutations in the gene encoding
filaggrin (FLG) located on chromosome 1q21 have been
identified as the cause of IV, and the disease was found to
exhibit semidominant inheritance (Smith et al., 2006).
Although sequence analysis for the highly repetitive FLG
gene has been considerably difficult, PCR protocols that
permit routine and comprehensive sequencing of the FLG
gene have recently been developed (Sandilands et al., 2007).
To date, 15 loss-of-function nonsense or frameshift mutations
in FLG, including two that are Oriental-specific, have been
identified by these sequencing methodologies (Nomura et al.,
2007; Sandilands et al., 2007).
Interestingly, a strong association between these FLG null
alleles and AD has also been firmly established (Palmer et al.,
2006). In Europe, this strong association has been extensively
replicated in several independent studies and, importantly,
no negative association study has been reported (Marenholz
et al., 2006; Ruether et al., 2006; Weidinger et al., 2006;
Barker et al., 2007; Morar et al., 2007; Sandilands et al.,
2007; Stemmler et al., 2007; Weidinger et al., 2007), as
reviewed recently (Irvine, 2007). In contrast, FLG variants in
non-European populations have not been fully analyzed so
far. The extent to which FLG mutations contribute to AD in a
global context remains to be evaluated, as AD is undoubtedly
a worldwide problem.
Early in 2007, we identified two Oriental-specific FLG
mutations in four Japanese families with IV and reported that
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the mutations were also predisposing factors for AD in Japan
(Nomura et al., 2007). This showed that the same gene is
involved in AD susceptibility in a non-European population.
However, the frequency of heterozygous, compound hetero-
zygous, and homozygous FLG mutation carriers observed in
our Japanese AD case series was only 5.6% (Nomura et al.,
2007), which was much lower than that seen in analogous
European AD case series, where it is more than 40% (Barker
et al., 2007; Sandilands et al., 2007). This suggested that there
may be further prevalent mutations to be discovered in the
Japanese population.
As the filaggrin gene is large and difficult to analyze and,
furthermore, as AD is undoubtedly genetically heteroge-
neous, a useful strategy for identifying filaggrin mutations in a
given population is to first concentrate on IV patients in
whom likely filaggrin mutation carriers can be readily
identified clinically. Once mutations are identified by
sequencing, rapid genotyping tests can then be developed
to study the overall population incidence and to allow
case–control association studies in AD (Palmer et al., 2006;
Smith et al., 2006; Sandilands et al., 2007). Here, we have
applied this strategy by studying seven Japanese families with
IV, allowing identification of two additional FLG mutations.
Subsequently, we have shown that these FLG mutations are
also highly significant predisposing factors for AD in Japan.
RESULTS
Clinical and pathological features
In total, seven newly identified Japanese kindreds with IV
were studied (Figure 1). The clinical phenotype consisted of
variable scaling, dry skin, and palmoplantar hyperlinearity
(Figure 2). All probands had a family history, but the clinical
severity varied considerably among family members. There-
fore, the inheritance pattern was consistent with semidomi-
nance, as reported previously (Sandilands et al., 2006; Smith
et al., 2006). More than half of these IV patients had
concomitant AD and several also had other symptoms
of atopic disease, including asthma and allergic rhinitis
(Figure 1).
In some cases, the diagnosis was also confirmed by skin
biopsy. Light microscopy of the lesional skin samples from
the proband in family 6 showed hyperkeratosis and markedly
reduced keratohyalin granules. Immunohistochemically, the
proband and his elder brother showed a marked reduction in
staining for filaggrin, whereas normal control skin was
stained strongly (Figure 2). Interestingly, the proband also
showed a greater reduction in filaggrin staining intensity
compared to his brother, who had a mild IV phenotype
(Figure 2).
Further filaggrin mutations in Japanese IV families
Twenty-three individuals from seven unrelated Japanese IV
families were screened for mutations within the FLG gene.
Initially, all families were screened for the previously
reported Japanese-specific FLG mutations 3321delA and
S2554X by fluorescent PCR and restriction enzyme digestion,
respectively, and then confirmed independently by direct
DNA sequencing (Nomura et al., 2007). We identified these
two mutations in five out of the seven families studied here
(Figure 1; families 1–5).
However, the probands from families 6 and 7 were wild
type for both mutations, despite showing typical IV pheno-
types. Thus, we carried out comprehensive sequencing of the
FLG gene, using the recently developed overlapping PCR
strategy that allows routine diagnostic sequencing of the
entire filaggrin coding sequence (Sandilands et al., 2007).
This led to the identification of FLG mutation, S2889X, in the
proband of family 6 (Figure 3). This mutation was shown to
be the paternal mutation. In contrast, the proband’s mother
and brother were both wild type for this mutation, although
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Figure 1. Pedigrees of IV families studied. Family trees of IV families show the semidominant inheritance pattern. Solid symbols refer to the marked IV
presentation; cross-hatched symbols refer to the milder IV presentation. In addition, more than half of the IV patients had concomitant dermatologist-diagnosed
AD (*). wt, wild type for FLG mutations.
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they also showed a typical IV phenotype. In addition, the
proband in family 6 showed a much more severe phenotype
than other affected family members and, furthermore,
immunohistochemistry showed a greater reduction in epi-
dermal filaggrin expression as compared to his more mildly
affected brother (Figure 2). Thus, it was predicted that this
severely affected proband was a likely compound hetero-
zygote. Further sequencing of the FLG gene was carried out
and another FLG mutation, S3296X, was identified. The
proband was therefore compound heterozygous for S2889X
and S3296X, and his mother and brother were heterozygous
for S3296X (Figure 3). Mutations S2889X and S3296X lead to
premature termination of profilaggrin translation in filaggrin
repeat domain 8.2 (one of the recently identified duplicated
repeats; Sandilands et al., 2007), and repeat domain 9,
respectively.
The proband and his mother in family 7 were also found to
be heterozygous carriers of S2889X, consistent with their
milder IV phenotype. Both of these newly identified muta-
tions were confirmed independently by restriction digestion
(Figure 3). The Japanese IV families studied here were also
confirmed to be wild type for all 13 FLG mutations found in
European populations (Sandilands et al., 2007), by direct
DNA sequencing.
Prevalent FLG mutations are predisposing factors for AD in
Japan
A total of 102 unrelated patients with AD were screened for
mutations S2554X, S2889X, and S3296X by restriction
digestion and for 3321delA by sizing of fluorescently labeled
PCR fragments. The presence of the mutations was indepen-
dently confirmed by direct DNA sequencing of PCR products.
The FLG genotype data in the Japanese AD case series and an
ethnically matched population control series are summarized
in Table 1.
Interestingly, all the mutations found in the Japanese IV
families were also identified in the Japanese AD population.
Mutations S2554X, S2889X, S3296X, and 3321delA were
found to be carried by 6 (5.9%), 10 (9.8%), 3 (2.9%), and 4
(3.9%) individuals in the Japanese AD case series, respec-
tively. The combined minor allele frequency in the case
series was observed to be 0.111 (95% confidence intervals
0.068–0.153). These mutations were also carried by 4 out of
133 unrelated general Japanese control individuals but at a
much lower combined minor allele frequency of 0.015 (95%
CI 0.000–0.030). These controls were not examined in
relation to AD or IV status, that is, they are population
controls, not ‘‘hypernormal’’ controls screened for the
absence of IV/AD. This observed association between the
combined FLG null variant genotypes and AD was statisti-
cally highly significant. Comparing the AD cohort and
population cohort for the combined null alleles yielded a
Pearson w2 P-value of 8.4106. Similarly, the Fisher exact
test odds ratio for heterozygotes was highly significant (OR
7.57, 95% CI 2.84–23.03). The numbers of homozygotes/
compound heterozygotes was too small in this study to allow
calculation of a homozygote odds ratio. More than 20% of
the individuals in the AD case series carried one or more of
these four FLG mutations.
DISCUSSION
The human profilaggrin gene (FLG) is located on chromo-
some 1q21 and consists of three exons. Exons 1 and 2 are
small, whereas exon 3 is unusually large (412 kb) and
encodes all filaggrin repeats that are almost 100% identical at
the DNA level, making PCR and sequence analysis difficult
(Sandilands et al., 2007). Furthermore, some individuals
show duplication of filaggrin repeat 8 and/or 10, which
results in size variation of the FLG gene within the human
population and further complicates routine sequence analysis
a b
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Figure 2. Clinicopathological features of patients with IV in family 6.
(a–d) Fine scaling clearly visible (a) on the proband’s leg and (b) on his elder
brother’s leg. (c, d) Both of them also have apparent palmar hyperlinearity.
The (a, c) proband showed more severe IV phenotype than (b, d) his elder
brother. (e–g) Immunohistochemical staining using anti-filaggrin monoclonal
antibody against an epitope conserved in all filaggrin peptides. The (e)
proband and (f) his brother showed a marked reduction in staining for
filaggrin, whereas (g) normal control skin was stained strongly. Scale
bar¼ 50 mm (e–g).
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(Sandilands et al., 2007). Despite these difficulties, methods
that enable sequencing of all coding regions of the FLG gene
have been recently developed by identifying a restricted
number of bases that are (a) specific to a particular repeat and
(b) relatively non-polymorphic. These specific bases allow
placement of primers for repeat-specific PCR and sequencing
(Sandilands et al., 2007).
Using this methodology, we identified two additional FLG
mutations, S2889X and S3296X, in Japanese individuals.
These mutations are located in filaggrin repeats 8 and 9,
respectively, and so truncated profilaggrin is likely to be
produced from these mutant alleles. As previous immunoblot
analysis of R501X/R2447X and R501X/11033del4 compound
heterozygotes showed that truncated profilaggrin protein
species are not processed into filaggrin (Sandilands
et al., 2007), we would therefore predict that S2889X and
S3296X have similar pathogenicity to the common European
repeat 1 mutations with respect to IV. Indeed, the proband in
family 6, compound heterozygous for S2889X and S3296X
identified here, showed a more clinically severe IV pheno-
type similar to that seen in individuals who harbor mutations
in repeat 1 (Smith et al., 2006; Sandilands et al., 2007).
Immunohistochemistry also demonstrated a greatly reduced
amount of profilaggrin granules in the epidermis (Figure 2).
We also identified these FLG mutations in Japanese
patients with AD. Notably, we demonstrate here that more
than 20% of AD patients in our Japanese case series carry
these four FLG mutations (3321delA, S2554X, S2889X,
and/or S3296X), whereas 3% of ethnically matched
control individuals carry these mutations (minor allele
frequency¼ 0.015; n¼ 266). In the Japanese population,
there is a statistically highly significant association between
the four FLG mutations and AD (w2 P¼8.4 106; hetero-
zygote OR 7.57, 95% CI 2.84–23.03). Thus FLG mutations
are shown to be major predisposing factors for AD in Japan as
well as in Europe. In addition, all FLG mutations found in
Japan are also shown to be prevalent in this ethnic
population, analogous to the five prevalent mutations so far
identified in Europeans (Sandilands et al., 2007). This work
brings the total number of prevalent filaggrin mutations so far
identified in human populations studied to nine.
Several large cohort studies in Europe demonstrated that
FLG null mutations predispose to allergic phenotypes like
asthma and allergic rhinitis involved in the atopic march
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Figure 3. Mutation analysis of IV. (a) Two heterozygous transition mutations c.8666C-G and c.8667C-A were identified in the proband of family 6,
resulting in S2889X. Normal control sequence from filaggrin repeat 8 in exon 3, corresponding to codons 8660–8672. Both transition mutations were
confirmed to exist on the same allele by cloning and sequencing of PCR products. (b) A heterozygous transition mutation c.9887C-A was also identified
in the proband of family 6, resulting in S3296X. Normal control sequence from filaggrin repeat 9 in exon 3, corresponding to codons 9881–9893. (c) Screening
family 6 for the mutation S2889X by BamHI restriction digest and S3296X by DpnII restriction digest. Arrows indicate the additional bands specific to the
mutant alleles. Individuals I-1 and II-2 were heterozygous for S2889X, whereas I-2 and II-1 were wild type. Similarly, individuals I-2, II-1, and II-2 were
heterozygous for S3296X, whereas I-1 was wild type.
Table 1. Atopic dermatitis case–control association analysis for FLG null variants in Japan
S2554X S2889X S3296X 3321delA Combined
Genotypes Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases
AA 132 96 131 92 133 99 132 98 129 81
Aa 1 6 2 10 0 3 1 4 4 19
aa 0 0 0 0 0 0 0 0 0 2
Totals 133 102 133 102 133 102 133 102 133 102
w2 P=0.022 P=0.004 P=0.047 P=0.095 P=8.4106
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(Marenholz et al., 2006; Weidinger et al., 2006) and to early-
onset AD phenotype persisting into adulthood (Barker et al.,
2007; Weidinger et al., 2007). Recently, FLG null mutations
have also been reported to be associated with increased
asthma severity (Palmer et al., 2007). Therefore, FLG null
mutations are indicative of a more severe, persistent
phenotype, and so screening for FLG mutations is emerging
as a useful prognostic indicator in atopy.
In conclusion, we have identified two further prevalent
FLG variants in the Japanese population. We also demon-
strate that these four known FLG null variants are highly
significant predisposing factors for AD in Japan. These data
emphasize the importance of screening for FLG mutations in
patients with IV and/or AD. It seems quite possible that FLG
null variants are also predisposing factors for AD in most
other races worldwide to differing degrees. Future analysis of
FLG variants in other races will reveal the overall contribu-
tion of this gene to the pathogenesis of atopy and the
subsequent global healthcare burden.
MATERIALS AND METHODS
Clinical materials
Blood samples were obtained from 23 patients with IV from
7 independent Japanese families and a further 102 unrelated
Japanese AD patients. The diagnosis of IV and AD was performed
clinically by experienced dermatologists. The diagnosis of AD was
performed using the AD diagnostic criteria by Hannifin and Rajka
(1980). For general controls, DNA samples from 133 unrelated
Japanese individuals were included in the current study. Patients
gave written informed consent, which complies with all the
Declarations of Helsinki Principles. This study was approved by
the Medical Ethical Committees of the Hokkaido University,
Sapporo, Japan.
Filaggrin genotyping
FLG mutation analysis was performed in patients and their family
members. Briefly, genomic DNA isolated from peripheral blood was
subjected to PCR amplification, followed by direct automated
sequencing using ABI PRISM 3100 or 3730 genetic analyzers
(Applied Biosystems, Foster City, CA). Mutation S2554X was
screened using restriction enzyme digestion of PCR products
(Nomura et al., 2007). Mutation 3321delA was screened by
fluorescent PCR (Nomura et al., 2007). Primers and PCR conditions
were as described previously (Nomura et al., 2007).
Mutation detection and screening for S2889X and S3296X
A 878-bp PCR product from repeat 8 of the FLG gene was amplified
with forward primer 50-GATGGACGGGGCCCAGCACTA-30 and
reverse primer 50-CTTGGTGGCTCTGCTGATGGGA-30. A total of
100 ng genomic DNA was amplified using High Fidelity PCR buffer
(Roche Diagnostics Ltd., Lewes, UK) containing 1.5mmol l1 MgCl2,
4% (vol/vol) DMSO, and 1U of Expand High Fidelity enzyme
(Roche). PCR amplification conditions were as follows: 1 cycle of
941C for 5minutes, 32 cycles of 941C for 30 seconds, 641C for
30 seconds, and 721C for 1minute; then 1 cycle of 721C for
5minutes. The 878-bp PCR fragment was sequenced with the
amplification primers (above). The PCR products were also cloned
into a plasmid vector (TA cloning kit, Invitrogen, Carlsbad, CA) and
sequenced to confirm that the two point mutations detected were on
the same allele. Mutation S2889X abolishes a BamHI restriction
enzyme site. PCR products were digested with 20U of BamHI (New
England Biolabs, Ipswich, MA) at 371C for 1 hour. Digests were
resolved on 3% (w/v) agarose gels. The mutant allele was resolved as
438-, 207-, 200-, and 33-bp fragments, whereas the wild-type allele
yielded fragments of 274-, 207-, 200-, 164-, and 33-bp.
A 803-bp PCR product from repeat 9 of the FLG gene was
amplified with forward primer 50-TCTGTTCAGGAGCAGTCAAGG-30
and reverse primer 50-GCTTCATGGTGATGCGACCA-30. A total of
100 ng genomic DNA was amplified using High Fidelity PCR buffer
(Roche) containing 1.5mmol l1 MgCl2, 4% (vol/vol) DMSO, and
1U of Expand High Fidelity enzyme (Roche). PCR-amplification
conditions were as follows: 1 cycle of 941C for 5minutes, 35 cycles
of 941C for 30 seconds, 601C for 30 seconds, and 721C for 1minute;
then 1 cycle of 721C for 5minutes. The 803-bp PCR fragment was
sequenced with the amplification primers (above). Mutation S3296X
abolishes a DpnII restriction enzyme site. PCR products were
digested with 20U of DpnII (New England Biolabs) at 371C for
1 hour. Digests were resolved on 3% (w/v) agarose gels. The mutant
allele was resolved as 327-, 183-, 105-, 102-, and 86-bp fragments,
whereas the wild-type allele gave fragments of 327-, 159-, 105-,
102-, 86-, and 24-bp.
Statistical analysis
In this study, case–control association analyses were performed by
using Pearson w2 and Fisher exact test statistics, as described
previously (Palmer et al., 2006). All alleles were observed to be in
normal Hardy–Weinberg equilibrium.
Immunohistochemical analysis
Immunoperoxidase staining of paraffin-embedded sections was
performed by using the ChemMate Peroxidase/DAB system (Dako-
Cytomation, Hamburg, Germany). Mouse mAb 15C10 (Novocastra,
Newcastle, UK) was used to detect the human filaggrin repeat unit.
Importantly, antigen retrieval of paraformaldehyde-fixed, paraffin-
embedded sections was performed by heating sections under
pressure for 10–15minutes in 10mmol l1 citrate buffer, pH 6.0.
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